ROS1--targeting the one percent in lung cancer
- PMID: 25409376
- DOI: 10.1056/NEJMe1411319
ROS1--targeting the one percent in lung cancer
Comment on
-
Crizotinib in ROS1-rearranged non-small-cell lung cancer.N Engl J Med. 2014 Nov 20;371(21):1963-71. doi: 10.1056/NEJMoa1406766. Epub 2014 Sep 27. N Engl J Med. 2014. PMID: 25264305 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical